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SUMMARY
We sought to determine the frequency of serological markers of selected infections in a population of psychiatric patients in
Durango City, Mexico, and to determine whether there are any epidemiological characteristics of the subjects associated with the
infections. One hundred and five inpatients of a public psychiatric hospital of Durango were examined for HBsAg, anti-HCV
antibodies, anti-HIV antibodies, anti-Brucella antibodies, rapid plasma reagin and anti-Cysticercus antibodies by commercially
available assays. Anti-Cysticercus antibodies were confirmed by Western blot and HBsAg by neutralization assay. Epidemiological
data from each participant were also obtained. Seroprevalences of HBsAg, anti-HCV, anti-HIV, anti-Brucella, rapid plasma reagin
and anti-Cysticercus antibodies found were 0.0%, 4.8%, 0.9%, 0.0%, 1.9%, and 0.9%, respectively. Overall, 9 (8.6%) inpatients
showed seropositivity to any infection marker. We concluded that our psychiatric inpatients have serological evidence of a number
of infections. HCV is an important pathogen among our psychiatric inpatients. Health care strategies for prevention and control of
infections in Mexican psychiatric patients should be considered.
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INTRODUCTION
Psychiatric patients have been found to suffer from a number of
infections in a higher frequency than other populations, and the
prevalence of infections in psychiatric patients may vary substantially
among countries. Prevalence studies indicate that psychiatric patients
have a significantly higher frequency of anti-Cysticercus antibodies
than those observed in the general population or healthy control
subjects. In a Venezuelan study, 18.4% of the psychiatric inpatients
studied were positive in the blood test for cysticercosis as compared
to only 1.6% prevalence in the control group7. Similarly, a study
carried out in Brazil showed that 5% of the patients admitted to a
psychiatric hospital were positive for anti-Cysticercus antibodies
while only 2.3% prevalence was found in adults of the general
population group12. Reports also indicate that patients with mental
illnesses have a high prevalence of human immunodeficiency virus
(HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV)
infections. In an American study, researchers found that the prevalence
of HIV in individuals with severe mental illness was approximately
eight times the estimated US population rate, and prevalence rates of
HBV and HCV were approximately five and 11 times the overall
estimated population rates for these infections, respectively10. In an
Indian study, newly registered adult psychiatric outpatients at a
general hospital showed significantly higher seroprevalence of HIV
infection than healthy blood donors (1.03% versus 0.5%,
respectively)11. For its part, patients with Brucella infection may
manifest central nervous system involvement, and neurobrucellosis
should be considered in patients with unexplained psychiatric and
neurological symptoms6,13. Treponema pallidum infections should be
also borne in mind as a differential diagnosis in a number of
neurological and psychiatric illnesses3. The epidemiology of
infections in psychiatric patients in Mexico has been poorly explored.
Therefore, we conducted a cross-sectional survey in order to
determine the frequency of selected infections in a population of
inpatients of a psychiatric hospital of Durango City, Mexico. In
addition, we sought to determine whether any epidemiological
characteristics of the patients correlated with the infections.
MATERIALS AND METHODS
Study population: One hundred and five inpatients of a public
psychiatric hospital (Hospital de Salud Mental, Dr. Miguel Vallebueno)
in Durango City, Mexico were studied. This hospital attends psychiatric
patients of both urban and rural areas of Durango State, however, the
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great majority of patients attended comes from urban areas. In addition,
most inpatients are homeless and less than 1% has a history of
incarceration. All subjects were screened from December 2005 to March
2006. This study was evaluated and accepted by the Institutional Ethical
Committee. A written informed consent was obtained from all
participants of the study.
Serology for anti-Taenia solium antibodies: Serum samples from
the psychiatric patients were analyzed for anti-Taenia solium antibodies
by an Enzyme Linked Immunoabsorbant Assay: Cysticercosis (Taenia
solium) (Diagnostic Automation, Inc. Calabasas, CA, USA).
Confirmation of serum anti-Cysticercus antibodies was performed by
Western blot as described elsewhere7.
Serology for viral infection markers: HBV surface antigen
(HBsAg), anti-HCV and anti-HIV antibodies were determined in
patients by means of the Microparticle Enzyme Immunoassays HBsAg
(V2), HCV version 3.0, and HIV 1 / 2 gO, respectively. All these kits
were manufactured by Abbott Diagnostics (Wiesbaden, Germany), and
were run in the Abbott AXSYM system (Abbott Laboratories, Chicago,
USA).
Serology for brucellosis and syphilis: Anti-Brucella antibodies
and rapid plasma reagin were detected in patients by the Rose Bengal
plate agglutination test (Laboratorios MICSA, FD, Mexico) and by
rapid plasma reagin (RPR) test (Laboratorios Licon, S.A, Tlalnepantla,
Mexico), respectively.
Epidemiological data: Socio-demographic data including age,
gender, and socio-economic level were obtained from all patients.
Clinical data including psychiatric diagnosis, history of drug use,
transplantation, haemodialysis, piercing, blood transfusion, sexual
promiscuity, sexual practices, and surgery from the patients were also
obtained. In addition, behavioural data including animal contacts,
foreign travel, unpasteurized milk or milk products consumption,
untreated water consumption, unwashed raw vegetables or fruits
consumption, contact with soil (gardening or agriculture), and eating
outside of the home from the patients studied were obtained. In the
psychiatric patients, data was obtained from the patients, medical
examination records, and informants. Classification of mental illnesses
was performed according to the ICD-10 criteria2.
Statistical analysis: Analysis of results was performed with the
aid of the software Epi Info 6. For comparison of the frequencies among
the groups, the Fisher exact test was used. A p value of less than 0.05
was considered significant.
RESULTS
Epidemiological data: Of the 105 psychiatric patients studied, 35
were women and 70 were men. The mean age was 46.5 years (range:
18 to 83 years). Patients suffered from a number of mental illnesses
including schizophrenia (F20, n = 27), mental and behavioral disorders
due to psychoactive substance use (F19, n = 25), mental retardation
(F71-73, n = 18), mental disorder (F06.8, n = 16), mental and behavioral
disorders due to use of alcohol (F10, n = 7), bipolar affective disorder
(F31, n = 5), dementia of the Alzheimer type (F00, n = 2), epilepsy
(G40, n = 2), severe depression episode (F32.2-3, n = 2), and vascular
dementia (F01, n = 1). History of intravenous drug use, piercing, and
blood transfusion were found in one (0.9%), 12 (11.4%), and three
(2.9%) patients, respectively. While history of surgery, sexual
promiscuity, and homosexuality were found in 35 (33.3%), 16 (15.2%),
and one (0.9%) patients, respectively. History of transplantation and
hemodialysis was not present in any patient.
Serology for anti-Taenia solium antibodies: Out of the 105
patients studied, eight (7.6%) were positive for anti-Taenia solium
antibodies by the enzyme immunoassay. All positive samples for anti-
Taenia solium antibodies were further analyzed by Western blot and
only one sample was confirmed positive, therefore the prevalence of
anti-Taenia solium antibodies was 0.9%.
Serology for HBsAg, anti-HCV and anti-HIV antibodies: None
of the patients was positive for HBsAg. Out of the 105 patients studied,
five (4.8%) were positive for anti-HCV antibodies, and one (0.9%)
was positive for anti-HIV antibodies.
Serology for anti-Brucella antibodies and RPR: Anti-Brucella
antibodies were not present in any patient. Out of the 105 patients
studied, two (1.9%) were positive for RPR.
DISCUSSION
In this study, we found that our psychiatric inpatients have a
serological evidence of a number of infections in general, and a
high prevalence of anti-HCV antibodies in particular. The 4.8%
prevalence of anti-HCV antibodies found in our psychiatric
population was much higher than those reported in studies of
Mexican blood donors. For instance, CARRETO-VELEZ et al.1 and
LADRÓN DE GUEVARA et al.5 found 1.1% and 0.8%
seroprevalence of anti-HCV antibodies in large groups of Mexican
blood donors, respectively. The prevalence of anti-HCV found in
our psychiatric patients is also higher than that observed in blood
donors in local public blood banks (less than 0.5%, unpublished
data). Similarly, although in less extent than HCV, our 0.9%
prevalence of anti-HIV antibodies in psychiatric patients seems to
be higher than those found in Mexican blood donors. We found an
anti-HIV antibodies case in about 100 patients, while an anti-HIV
antibodies case in about 400 Mexican blood donors has been
reported5. Our results on the prevalence of anti-HCV and anti-HIV
antibodies in psychiatric patients are comparable with those reported
in a Spanish study where researchers found a seroprevalence of
HCV and HIV infections in psychiatric patients of 5.1% and 1.4%,
respectively4. In contrast, our frequencies of HCV and HIV
infections in psychiatric patients are lower than those reported in
an American study where researchers found HCV and HIV infections
in 14.4% and 3.0% of patients with severe mental illness,
respectively9.
With respect to bacterial infection markers, we found two (1.9%)
patients positive for RPR. Although the frequency of RPR seropositivity
found in psychiatric patients was low, results suggest that psychiatric
patients may have a higher frequency of RPR seropositivity than healthy
populations of Mexico. For instance, in a large group of Mexican blood
donors, PITA-RAMIREZ et al.8 found a proportion of one positive
RPR case in about 840 blood donors, while we found a proportion of
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one case in about 50 psychiatric patients. In addition, the frequency of
positive RPR cases among blood donors of our community is much
lower (less than 0.1%, unpublished data) than the one found in our
psychiatric patients.
Concerning the prevalence of anti-Cysticercus antibodies in our
psychiatric patients, we found only one positive case. Results suggest
that cysticercosis seems not to represent a major health problem in our
psychiatric population. Nevertheless, our prevalence is lower than that
reported in a Brazilian study where researchers found a 5.0% prevalence
of anti-Cysticercus antibodies in patients of a psychiatric hospital12.
Similarly, in a Venezuelan study, chronic psychiatric inpatients showed
a prevalence of 18.4% of anti-Cysticercus antibodies7.
We were unable to obtain any association between infections and
the sociodemographic, clinical, and behavioral characteristics of the
infected individuals. The low number of patients with positive infection
markers found in this study reduces the statistical power to find
associations between seropositivity and the epidemiological
characteristics in psychiatric patients. Certainly by increasing the
sample size the statistical power increases and some risk factors might
turn out to become significant. This is especially interesting for risk
factors as substance abuse and blood transfusion. However, based on
the usual route of transmission of the infections found in this study, it
is possible that parenteral or sexual routes of infections are important
for infection acquisition in psychiatric patients.
General characteristics in patients and facilities in the psychiatric
hospital explored are similar to those found in the majority of public
psychiatric hospitals of Mexico. Results of this study may reflect,
although in a limited extent, the frequencies of the selected infections
in psychiatric patients of Mexico. However, further studies should be
conducted in order to determine the national magnitude of infections
as a public health problem in psychiatric patients of Mexico.
CONCLUSIONS
We conclude that our psychiatric inpatients have serological
evidence of a number of infections. HCV is an important pathogen
among our psychiatric patients. Health care strategies for prevention
and control of infections in Mexican psychiatric patients should be
considered.
RESUMO
Soroprevalência de infecções virais bacterianas e parasíticas nos
pacientes internados em hospital público psiquiátrico do México
Procuramos determinar a frequência de marcadores sorológicos
de infecções em pacientes psiquiátricos da cidade de Durango, México
e determinar se existem características epidemiológicas dos pacientes
que podem ser associados a estas infecções. Cento e cinco pacientes
internados neste hospital psiquiátrico de Durango foram examinados
para HBsAg, anticorpos anti-HCV, anticorpos anti-HIV, anticorpos anti-
Brucella, reaginas plasmáticos imediatas e anticorpos anti-Cysticercus
por testes comerciais. Os anticorpos anti-Cysticercus foram
confirmadoss por Western Blot e o HbsAg por testes de neutralização.
Dados epidemiológicos de cada participante foram também obtidos.
Soroprevalências encontradas de HbsAg, anti-HCV, anti-HIV, anti-
Brucella, reagina plasmática imediata e anticorpos anti-Cysticercus
foram respectivamente 0,0%, 4,8%, 0,9%, 0,0%, 1,9% e 0,9%. No
conjunto, 9 (8,6%) de pacientes internados mostraram soropositividade
para marcador infeccioso. Concluímos que nossos pacientes
psiquiátricos internados têm evidência sorológica de infecções. HCV
é um patógeno importante entre os pacientes psiquiátricos internados.
Estratégias de saúde pública para prevenção e controle de infecções
em pacientes psiquiátricos do México devem ser consideradas.
ACKNOWLEDGEMENTS
The authors acknowledge the support of Abigail Gurrola Hernandez
for her kind secretarial assistance, and the personnel of the State Center
for Blood Transfusion, Durango City: Carlos E. Luevanos Becerra,
Luis Felipe Martinez Saenz, Enriqueta Alvarado Aguilar, Marco
Antonio Gonzalez Cardoza, and Gabriel Perez Ochoa for their logistic
support in the study.
REFERENCES
1. CARRETO-VÉLEZ, M.A.; CARRADA-BRAVO, T. & MARTINEZ-MAGDALENO A.
- Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico.
Salud públ. Méx., 45(suppl. 5): S690-S693, 2003.
2. CLASIFICACIÓN ESTADÍSTICA INTERNACIONAL DE ENFERMEDADES Y
PROBLEMAS RELACIONADOS CON LA SALUD. 10. ed. 1995. Washington,
Organización Panamericana de la Salud, 1995. v. 1-3.
3. CONDE-SENDÍN M.A.; HERNÁNDEZ-FLETA, J.L.; CÁRDENES-SANTANA, M.A.
& AMELA-PERIS, R. - Neurosyphilis: forms of presentation and clinical
management. Rev. Neurol., 35: 380-386, 2002.
4. FERNÁNDEZ-EGEA, E.; GÓMEZ GIL, E.; CORBELLA SANTOMÀ, B. et al. -
Serological testing and prevalence of human immunodeficiency, hepatitis B and C
viruses infections amongst acute psychiatric inpatients. Med. clin. (Barcelona), 119:
690-692, 2002.
5. LADRÓN-DE GUEVARA, L.; GÓMEZ, N.; VÁZQUEZ-CANTARELL, M.; GARCÍA-
MÉNDEZ, S. & DI SILVIO, M. - Prevalence of and risk factors for hepatitis C in
blood donors. Rev. Gastroent. Méx., 67: 11-16, 2002.
6. MANTUR, B.G.; BIRADAR, M.S.; BIDRI, R.C. et al. - Protean clinical manifestations
and diagnostic challenges of human brucellosis in adults: 16 years’ experience in an
endemic area. J. med. Microbiol., 55: 897-903, 2006.
7. MEZA, N.W.; ROSSI, N.E.; GALEAZZI, T.N. et al. - Cysticercosis in chronic psychiatric
inpatients from a Venezuelan community. Amer. J. trop. Med. Hyg., 73: 504-509,
2005.
8. PITA-RAMIREZ, L. & TORRES-ORTIZ, G.E. - Prevalence of viral antibodies and
syphilis serology in blood donors from a hospital. Rev. Invest. clín., 49: 475-480,
1997.
9. ROSENBERG, S.D.; DRAKE, R.E.; BRUNETTE, M.F.; WOLFORD, G.L. & MARSH,
B.J. - Hepatitis C virus and HIV co-infection in people with severe mental illness
and substance use disorders. AIDS, 19(suppl. 3): S26-S33, 2005.
10. ROSENBERG, S.D.; GOODMAN, L.A.; OSHER, F.C. et al. - Prevalence of HIV, hepatitis
B, and hepatitis C in people with severe mental illness. Amer. J. publ. Hlth, 91: 31-
37, 2001.
11. THARYAN, P.; RAMALINGAM, S.; KANNANGAI, R. et al. - Prevalence of HIV
infection in psychiatric patients attending a general hospital in Tamil Nadu, south
India. AIDS Care, 15: 197-205, 2003.
164
ALVARADO-ESQUIVEL, C.; ARREOLA-VALENZUELA, M.A.; RODRÍGUEZ-BRIONES, A.; ALANÍS-QUIÑONES, O.P.; ESTRADA-MARTÍNEZ, S.; LUEVANOS-BECERRA, C.;
MARTÍNEZ-SAENZ, L.F.; MARTÍNEZ-GARCIA, S.A.; RAMÍREZ-VALLES, E.G.; IBARRA-TORRES, I. & GONZÁLEZ-VERDÍN, C.A. - Seroprevalence of selected viral, bacterial
and parasitic infections among inpatients of a public psychiatric hospital of Mexico. Rev. Inst. Med. trop. S. Paulo, 50 (3): 161-164, 2008.
12. VAZ, A.J.; HANASHIRO, A.S.; CHIEFFI, P.P. & FERREIRA, A.W. - Frequency of
patients with anti-Cysticercus cellulosae blood antibodies in 5 municipalities of the
state of São Paulo. Rev. Soc. bras. Med. trop., 23: 97-99, 1990.
13. YETKIN, M.A.; BULUT, C.; ERDINC, F.S.; ORAL, B. & TULEK N. - Evaluation of
the clinical presentations in neurobrucellosis. Int. J. infect. Dis., 10: 446-452, 2006.
Received: 5 March 2007
Accepted: 10 March 2008
